• Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts

    Source: Buzz FX / 01 Nov 2024 02:08:16   America/Chicago


    Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Shares of Immunome, Inc. ( NASDAQ:IMNM - Get Free Report ) have received an average recommendati
    Read more...
Share on,